NCGA News














NCGA Encouraged by European Commission Decision on Monsanto Corn (7-21-04)

The European Commission is on its way to approving the second corn event in six years. On Monday, the body approved Monsanto’s NK603 corn, also known as Roundup Ready 2, for feed and industrial use in the European Union (EU). The National Corn Growers Association (NCGA) welcomed the news and looks forward to future action by the commission on NK603 and other biotech products.

Despite this week’s announcement, NK603 cannot be marketed until the commission approves the application for food use. The European Council did not reach a qualified majority in their meeting and a final decision on NK603 will likely be delayed until October or November of this year.

“While the European regulatory system is beginning to move forward at a quicker pace, we still have concerns regarding EU member states that are strongly opposed to the technology,” said Helen Inman, chair of NCGA’s Biotechnology Working Group. “This news is encouraging, but we have a long way to go before the moratorium on biotech products is effectively ended.”

The EU decision came just a week after the Argentine government approved the NK603 event for cultivation. Argentine corn growers will likely have access to the technology next year. Experts expect the Argentine approval to have an impact on global adoption in the near-term, since both the United States and Argentina have permitted the corn event for commercialization. The United States and Argentina are the two largest exporters of corn, marketing a combined 2.3 billion bushels last year.

Monsanto estimates Roundup Ready corn seed was planted on 16 million acres in the United States this year, up from 12 million acres last year. Globally, Monsanto’s biotech crop acres grew to 172 million acres in 2004 from 150 million acres the previous year.

 

Last reviewed July 21, 2004



ST. LOUIS OFFICE


WASHINGTON D.C. OFFICE

632 Cepi Drive
Chesterfield, MO 63005
Phone: (636) 733-9004
FAX: (636) 733-9005
122 C Street, N.W., Suite 510
Washington, DC 20001
Phone: (202) 628-7001
FAX: (202) 628-1933